ArticleMolecular cancer therapeutics2018

Targeting the BRD4-HOXB13 Coregulated Transcriptional Networks with Bromodomain-Kinase Inhibitors to Suppress Metastatic Castration-Resistant Prostate Cancer.

Niveditha Nerlakanti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.